Related by context. All words. (Click for frequent words.) 67 ischemic stroke 67 recurrent VTE 67 ischemic strokes 65 hemorrhagic strokes 65 cardiovascular hospitalization 64 thrombotic events 63 reinfarction 63 ipsilateral stroke 63 cardiovascular disease CVD 62 myocardial infarction MI 62 nonfatal heart 62 atherothrombotic events 62 haemorrhagic stroke 62 osteoporotic fracture 62 sudden cardiac death 61 Erythropoietic therapies may 61 intracerebral hemorrhage 61 cardiovascular hospitalizations 61 vertebral fracture 61 venous blood clots 61 myocardial infarction 61 venous thromboembolic events 61 de ath 61 venous thrombosis 60 untreated sleep apnea 60 cardiovascular disease 60 NYHA Class II 60 invasive breast cancer 60 osteoporotic fractures 60 unstable angina 60 recurrent venous thromboembolism 60 upper gastrointestinal bleeding 60 nonvertebral fractures 60 acute myocardial infarctions 60 vertebral fractures 60 nonfatal stroke 60 cerebrovascular events 60 post thrombotic syndrome 60 elevated triglyceride levels 60 non valvular atrial 59 hemorrhagic complications 59 severe aortic stenosis 59 cardioembolic stroke 59 stroke transient ischemic 59 cardiovascular mortality 59 left ventricular dysfunction 59 CMV infection 59 ICDs implanted 59 gout flares 59 ischemic cardiomyopathy 59 thromboembolic 59 repeat revascularization 59 atherosclerotic disease 59 atrial fibrillation 59 proliferative diabetic retinopathy 59 recurrent ischemia 59 venous thromboembolisms 59 ruptured aneurysms 59 revascularization procedures 59 candesartan 59 rehospitalization 58 carotid artery disease 58 homozygous familial hypercholesterolemia 58 ischemic complications 58 myocardial infarctions 58 acute coronary syndrome 58 pyridostigmine 58 GERD symptoms 58 nonmelanoma skin cancer 58 TEAEs 58 silent ischemia 58 colorectal adenomas 58 migraineurs 58 venous thromboembolism 58 subclinical hypothyroidism 58 uncontrolled hypertension 58 cardiogenic shock 58 DVT PE 58 atrophic gastritis 58 proliferative retinopathy 58 hip fracture 58 VT VF 58 coronary artery disease 58 NATRECOR R 58 recurrent myocardial infarction 58 Exacerbations 58 PSADT 58 acute myocardial infarction AMI 58 postoperative AF 58 intermittent claudication 58 carotid stenosis 57 hemodialysis patients 57 infarction STEMI 57 hemorrhagic stroke 57 macrovascular disease 57 VTE 57 valsartan 57 myocardial infarction stroke 57 cryptogenic stroke 57 postoperative delirium 57 renal flares 57 definite stent thrombosis 57 angina chest 57 nonischemic 57 nonfatal MI 57 Major Depressive Disorder 57 MACCE 57 migraine sufferers 57 macrovascular 57 paclitaxel eluting stents 57 systemic embolism 57 prolonged QT interval 57 spontaneous preterm birth 57 hip fractures 57 acute coronary syndromes 57 undergoing coronary angiography 57 variceal bleeding 57 tolvaptan 57 extrapyramidal symptoms 57 ARCOXIA 57 hyperphenylalaninemia HPA due 57 recurrent ischemic stroke 57 recurrent atrial fibrillation 57 intracerebral hemorrhages 57 arterial thromboembolic events 57 severe hypoglycemic 57 microvascular disease 57 Atrial fibrillation affects 57 cerebral infarction 57 T1DM 57 prescribed statins 57 severe psoriasis 57 stable angina 57 cilostazol 57 ximelagatran 57 decompensated heart failure 57 venous thromboembolism VTE 57 recurrent coronary 57 ARIXTRA 57 RSV infections 57 benazepril 57 morphometric vertebral fractures 57 lower limb amputations 57 uncontrolled asthma 57 microvascular complications 57 asymptomatic PAD 57 nonfatal myocardial infarction 57 Intracerebral hemorrhage 56 hypertensive patients 56 thromboembolic events 56 antithrombotic therapy 56 PLX STROKE targeting 56 endometrial hyperplasia 56 atherothrombotic disease 56 afib 56 cerebrovascular accident 56 coronary disease 56 coronary heart 56 Sudden Cardiac Death 56 torsades de pointes 56 HeFH 56 defibrillator CRT D 56 coronary revascularization 56 carotid artery blockage 56 ICD implants 56 β blockers 56 T2DM 56 NYHA Class III 56 paroxysmal AF 56 Acute Coronary Syndromes 56 nonvertebral fracture 56 postoperative mortality 56 STEMI patients 56 myocardial infarctions MIs 56 nonmelanoma skin cancers 56 AVODART 56 ATACAND 56 underwent CABG 56 arterial thickening 56 XIENCE V PROMUS Stent 56 angina 56 colorectal adenoma 56 severe neutropenia 56 neovascular AMD 56 Venous thromboembolism 56 unstable angina chest 56 patients undergoing percutaneous 56 overactive bladder symptoms 56 rosuvastatin #mg 56 unstable angina pectoris 56 severe exacerbations 56 Malignant gliomas 56 NATRECOR ® 56 postoperative atrial fibrillation 56 VTEs 56 irreversible blindness 56 thyrotropin levels 56 refractory ischemia 56 CIPN 55 breast cancer recurrence 55 fragility fractures 55 Cardiovascular Events 55 abnormal mammograms 55 LV dysfunction 55 Ischemic strokes 55 paroxysmal atrial fibrillation 55 microalbuminuria 55 thrombotic complications 55 virologic failure 55 adjunctive ABILIFY 55 hysterectomies performed 55 chronic HCV infection 55 LQTS 55 atherothrombosis 55 AFib 55 refractory angina 55 intravenous bisphosphonates 55 lumbar spinal stenosis 55 FOLFOX4 55 pulmonary embolism PE 55 ruptured brain aneurysm 55 fatal arrhythmic 55 acute GVHD 55 asymptomatic carotid stenosis 55 aortic valve stenosis 55 syncopal 55 thrombolytic therapy 55 NYHA class 55 antihypertensive medications 55 diagnosable mental disorder 55 diabetes mellitus DM 55 recurrent wheezing 55 macrovascular events 55 CRVO 55 abnormal Pap test 55 ST elevation myocardial 55 subclinical atherosclerosis 55 aneurysmal subarachnoid hemorrhage 55 aspirin therapy 55 rosuvastatin 55 sudden cardiac arrest 55 fatal myocardial infarction 55 patients undergoing CABG 55 placebo controlled clinical 55 transient ischemic attack 55 neurologic complications 55 hypercholesterolaemia 55 symptomatic VTE 55 cardiac dysfunction 55 familial adenomatous polyposis 55 carotid artery narrowing 55 RE LY ® 55 chronic ITP 55 hypoglycemic episodes 55 tibolone 55 CIMZIA ™ 55 alteplase 55 incontinence episodes 55 RLS symptoms 55 lower extremity amputations 55 prasugrel uh prevented 55 elevated LDL cholesterol 55 Hemorrhagic strokes 55 occlusion CRVO 55 arrhythmias 55 Peripheral Arterial Disease 55 Osteoporosis affects 55 TAXUS Express Stent 55 oral FTY# 55 invasive candidiasis 55 primary generalized tonic 55 intracranial stenosis 55 autoantibody positive 55 diabetes mellitus 55 vWD 55 severe sepsis 55 severe hypoglycemia 55 fragility fracture 55 evaluable subjects 55 CYPHER Stent 55 hypoglycaemic episodes 55 ejection fractions 55 antihypertensive therapy 55 preserved ejection fraction 55 cirrhotic patients 55 statin 55 AAT deficiency 55 familial hypercholesterolemia 55 hyperglycaemia 55 acute ischemic stroke 55 undergoing coronary artery 54 OAB symptoms 54 endarterectomy 54 death reinfarction 54 atrial fibrillation AF 54 Primary Hypercholesterolemia 54 recurrent DVT 54 ACTOS 54 CHD CVD 54 acute coronary syndromes ACS 54 CYPHER R Sirolimus eluting 54 dyslipidaemia 54 overt nephropathy 54 PRADAXA 54 antithrombotic therapies 54 Ischemic stroke 54 subclinical hyperthyroidism 54 venous thromboembolic disease 54 estrogen progestin therapy 54 PAOD 54 pioglitazone 54 generalized edema 54 FROVA 54 heart disease 54 partial onset seizures 54 osteoporotic vertebral fractures 54 ICD implantation 54 adjunctive placebo 54 dapagliflozin plus 54 spontaneous preterm delivery 54 azacitidine 54 subarachnoid hemorrhages 54 postoperative complication 54 acute coronary 54 invasive cervical cancer 54 HbA1c levels 54 inhospital 54 Chronic Heart Failure 54 Generalized anxiety disorder 54 nonfatal myocardial infarction MI 54 KIF6 carriers 54 polyp recurrence 54 alemtuzumab treated 54 uncontrolled epilepsy 54 anticoagulants blood thinners 54 ticlopidine 54 vasomotor symptoms 54 chronic periodontitis 54 painful compression fractures 54 NAFLD 54 BRCA mutations 54 lipid lowering medications 54 persistent pulmonary hypertension 54 colorectal cancer incidence 54 valvular disease 54 statin therapy 54 anticlotting drugs 54 deep venous thromboses 54 endometrial cancers 54 tachyarrhythmias 54 adult chronic ITP 54 mitral regurgitation 54 ventricular arrhythmia 54 retinal vein occlusion 54 venlafaxine Effexor 54 discontinuations due 54 adenomatous polyps 54 dysglycemia 54 uterine cancers 54 contrast induced nephropathy 54 cerebrovascular accidents 54 antiplatelet therapy 54 hypertension 54 tissue plasminogen activator tPA 54 RSV infects 54 mycophenolate mofetil 54 subtrochanteric 54 Ischemic 54 everolimus eluting stents 54 symptomatic hypoglycemia 54 hypoparathyroidism 54 eptifibatide 54 renal dysfunction 54 CYPHER R Stent 54 ischemic cardiovascular 54 cardiac resynchronization 54 Rheumatoid arthritis affects 54 lobular breast cancer 54 eplerenone 54 PSVT 54 cerebrovascular diseases 54 Major depressive disorder 54 antiplatelet drugs 54 A1c levels 54 thiazide diuretic 54 tumor recurrence 54 Chronic Constipation 54 antiarrhythmic drug 54 cerebral vasospasm 54 squamous cell cancers 54 rebleeding 54 cardio vascular disease 54 thrombus aspiration 54 carotid IMT 54 systolic hypertension 54 Severe hypoglycemia 54 cerebral infarctions 54 non aspirin NSAIDs 54 coronary revascularization procedures 54 severe periodontitis 54 Abbott Trilipix 54 QTc interval 54 thromboembolism 54 intracranial hemorrhage ICH 54 tirofiban 54 receiving ISENTRESS 54 telmisartan 53 infarctions 53 acute myocardial infarction 53 APTIVUS r 53 daytime drowsiness 53 EDSS score 53 myocardial infarction ventricular fibrillation 53 Recurrent Stroke 53 symptomatic GERD 53 metastatic brain tumor 53 embolic stroke 53 oxycodone CR 53 standard chemotherapy regimen 53 STEMI 53 LHON 53 reperfusion therapy 53 intracranial atherosclerosis 53 episodic migraine 53 antiplatelet agent 53 nontraumatic 53 claudication 53 generalized seizures 53 onset atrial fibrillation 53 CMV disease 53 dose aspirin 53 recurrent miscarriage 53 herpes zoster 53 ARICEPT 53 Obstructive sleep apnea 53 ticagrelor 53 haemorrhagic strokes 53 non squamous NSCLC 53 perindopril 53 stenting 53 octreotide LAR 53 IBS C 53 untreated OSA 53 uncontrolled seizures 53 Overactive Bladder 53 Lamictal XR 53 ADHF 53 kidney transplant recipients 53 HBV infections 53 anterior uveitis 53 bisphosphonate therapy 53 thrombophilia 53 severe asthma exacerbations 53 asthma exacerbation 53 neural tube defect 53 Implantable cardioverter defibrillators 53 born preterm 53 prednisone prednisolone 53 anovulatory infertility 53 pCR 53 hyperkalemia 53 levodopa therapy 53 ischemic 53 noncardiac surgery 53 de aths 53 symptomatic BPH 53 CHD mortality 53 gallstone disease 53 Schizophrenia affects 53 pleural mesothelioma 53 TNF antagonist 53 heterozygous FH 53 Renal Cell Carcinoma RCC 53 receiving prophylactic anticoagulation 53 VaD 53 perioperative mortality 53 Myelodysplastic syndromes MDS 53 oral antidiabetic medication 53 open angle glaucoma 53 advanced adenomas 53 posttraumatic stress disorder PTSD 53 Critical limb ischemia 53 oral antidiabetic drugs 53 cerebral vascular disease 53 serum phosphate 53 Myocardial infarction 53 Sudden cardiac arrest 53 baseline HbA1c 53 white matter hyperintensities 53 infarcts 53 aortic stenosis 53 ventricular tachycardia VT 53 ventricular tachyarrhythmia 53 PGTC seizures 53 Peripheral Artery Disease 53 renal impairment 53 onset diabetes mellitus 53 hip BMD 53 CYPHER ® Stent 53 elevated uric acid 53 bone metastasis 53 coronary intervention 53 premenstrual syndrome PMS 53 corticosteroid dose 53 acute STEMI 53 multivessel disease 53 undergoing radical prostatectomy 53 exacerbations 53 COPD exacerbations 53 nonischemic cardiomyopathy 53 CRESTOR #mg 53 tardive dyskinesia TD 53 TZDs 53 febrile seizures 53 Severe Primary IGFD 53 Thrombolysis 53 hypoglycemic events 53 pneumococcal pneumonia 53 CYPHER ® 53 Severe sepsis afflicts 53 colorectal cancer 53 virological response 53 CABG surgeries 53 revascularization procedure 53 diabetic retinopathy 53 angioplasties stents 53 Diabetic Macular Edema 53 renal insufficiency 53 metformin sulfonylurea 53 heart arrhythmias 53 thromboembolic complications 53 endometrial cancer 53 COPD exacerbation 53 PONV 53 knee OA 53 disease progression 53 myocardial infarcts 53 primary hypercholesterolemia 53 undergone radical prostatectomy 53 cisplatin chemotherapy 53 nonobstructive CAD 53 androgen deprivation 53 Acute Ischemic Stroke 53 Chronic Migraine 53 anticoagulant warfarin 53 ventricular remodeling 53 relapsing MS 53 antiepileptic drug 53 acute decompensation 53 perioperative complications 53 ACUITY trial 53 coronary interventions 53 familial ALS 53 hypersensitivity reaction 53 glycated hemoglobin levels 53 Venous stasis ulcers 53 nonfasting triglyceride levels 53 candidemia 53 NSAID 53 stable angina pectoris 53 VIIBRYD 53 PRADAXA #mg 53 cerebrovascular 53 intracranial bleeding 53 virological failure 53 COPAXONE R 53 resuscitated cardiac arrest 53 peginterferon alfa 2a 53 MIs 53 antiplatelet medication 53 MADIT II 53 Chronic insomnia 53 carotid atherosclerosis 53 Unstable Angina 53 generalized tonic clonic seizures 53 cognitive impairment 53 binary restenosis 53 recombinant tissue plasminogen 52 folate supplementation 52 potassium sparing diuretics 52 aspirin clopidogrel 52 Thromboembolism 52 stent thrombosis blood clots 52 hypercalcaemia 52 chronic GVHD 52 warfarin therapy 52 gestational hypertension 52 oral anticoagulant 52 severe oral mucositis 52 #.#/#.# mmHg [001] 52 ExTRACT TIMI 52 artery blockages 52 gestational diabetes 52 CVD mortality 52 Torsades de Pointes 52 salmeterol inhalation powder 52 PASI scores 52 chronic migraine 52 Cardiovascular Risk 52 TORISEL 52 Keppra R 52 hypopituitarism 52 acute PAO 52 spine fractures 52 invasive aspergillosis 52 Ischemic Stroke 52 angiotensin receptor blockers 52 symptomatic intracranial 52 IPAH 52 cardiovascular morbidity 52 EDSS scores 52 vaso occlusive crisis 52 coronary calcification 52 tenecteplase 52 Events MACE 52 Peripheral arterial disease 52 pharyngeal cancer 52 plus methotrexate 52 CINV 52 nonalcoholic steatohepatitis 52 knee osteoarthritis OA 52 angiotensin receptor blockers ARBs 52 Multiple sclerosis affects 52 pulmonary exacerbation 52 Transient Ischemic Attack 52 noncardiovascular mortality 52 nonfatal cardiovascular 52 AA Amyloidosis 52 angiotensin converting enzyme inhibitor 52 perimenopausal women 52 tiotropium 52 MetS 52 annualized relapse 52 symptomatic carotid stenosis 52 serum uric acid 52 torsade de pointes 52 myocardial infarctions MI 52 intracerebral haemorrhage 52 DETROL LA 52 uncontrolled bleeding 52 peripheral arterial disease 52 Hypotension 52 del 5q MDS 52 sustained virologic response 52 thrombolytic agents 52 intravitreal injections 52 febrile seizure 52 EXJADE 52 stent implantation 52 onset seizures 52 myocardial ischemia 52 prediabetes 52 rhythm disturbances 52 Deep vein thrombosis 52 osteoporotic 52 recurrent miscarriages 52 pulmonary embolisms 52 recurrent UTI 52 lamotrigine 52 elevated depressive symptoms 52 postoperative complications 52 antiepileptic drugs AEDs 52 events MACE 52 Hemorrhagic stroke 52 PREZISTA r 52 urinary symptoms 52 chronic ITP patients 52 target lesion revascularization 52 mixed hyperlipidemia 52 ICD therapy 52 chronic thromboembolic pulmonary 52 malignant neoplasm 52 ventricular arrhythmias 52 XIENCE V demonstrated 52 NPH insulin 52 parkinsonian symptoms 52 PFO closure 52 dengue hemorrhagic fever 52 non metastatic osteosarcoma 52 subsyndromal 52 chronic idiopathic thrombocytopenic purpura 52 abnormal uterine bleeding 52 zoledronic acid 52 habitual snoring 52 Serious adverse reactions 52 aneurysms 52 INTEGRILIN R 52 endometriosis ovarian cysts 52 deferiprone 52 LVEF 52 periprocedural 52 menstrual migraine 52 severe rotavirus gastroenteritis 52 juvenile idiopathic arthritis 52 SJIA 52 neurodevelopmental impairment 52 aneurysmal rupture 52 Estrogen deficiency 52 Restenosis 52 testosterone deficiency 52 ribavirin therapy 52 artery reclogging 52 Chronic ITP 52 detrusor overactivity 52 left ventricular hypertrophy 52 necrotizing pancreatitis 52 bone metastases 52 hemoglobin A1c HbA1c 52 lactic acidosis 52 microbleeds 52 NSTEMI 52 Hydroxyurea 52 neurologic progression 52 dopaminergic therapy 52 corrected QT interval 52 bypass graft CABG surgery 52 Ophena TM 52 diastolic heart 52 vulvovaginal atrophy 52 cardiac resynchronization therapy 52 fulminant hepatitis 52 #mg/dL [001] 52 lipid lowering therapy 52 enoxaparin 52 sustained ventricular tachycardia 52 BPH symptoms 52 fingolimod 52 Subarachnoid hemorrhage 52 relapsed ALL 52 dalteparin 52 Obstructive Sleep Apnea 52 Diovan HCT 52 thromboses 52 Nesiritide 52 cerebrovascular disease 52 awaiting kidney transplants 52 vasospasm 52 IIIa inhibitor 52 plasma folate 52 lupus nephritis 52 Aortic stenosis 52 hypoglycemia 52 rectal cancer 52 juvenile myoclonic epilepsy 52 aldosterone antagonist 52 lobular cancer 52 clopidogrel 52 nonadherence 52 Prostatitis 52 acromegalic patients 52 percutaneous coronary interventions 52 morbidity mortality 52 Acute Coronary Syndrome 52 relapsed MM 52 undergo bariatric surgery 52 candesartan cilexetil 52 nondiabetic patients 52 revascularizations 51 transient ischemic attacks 51 nocturnal hypoglycaemia 51 HNSCC 51 undergoing bariatric surgery 51 fewer uterine cancers 51 RLAI 51 Coronary artery disease 51 Juvenile Idiopathic Arthritis 51 proximal DVT 51 postmenopausal breast cancer 51 invasive ductal 51 NOMID 51 post herpetic neuralgia PHN 51 gouty arthritis 51 bivalirudin 51 blood Phe levels 51 EDARBI 51 advanced adenoma 51 Bipolar disorder affects 51 metformin accumulation 51 adenoma recurrence 51 angiographic restenosis 51 dual antiplatelet therapy 51 failure NYHA 51 Thrombocytopenia 51 clopidogrel Plavix 51 tapentadol ER 51 NNRTI resistance 51 CRBSIs 51 untreated obstructive sleep 51 brain metastases 51 Atrial fibrillation AF 51 reinterventions 51 diabetic gastroparesis 51 COPD 51 Antihypertensive 51 progressive neurodegenerative disorder 51 Scale EDSS score 51 hepatic cirrhosis 51 irritable bowel syndrome IBS 51 rimonabant #mg 51 mL/min/#.# m 2 51 endometrial carcinoma 51 chronic hepatitis B. 51 optic neuropathy 51 benign prostatic hypertrophy 51 cardiovascular disease hypertension 51 Natalizumab 51 cerebral ischemia 51 Diabetic retinopathy 51 herpes zoster infection 51 lower limb amputation 51 glucocorticoid therapy 51 T2D 51 venous thromboembolic 51 intracerebral hemorrhage ICH 51 ACTOplus met XR 51 tamoxifen Nolvadex ® 51 revascularization 51 basal cell carcinoma BCC 51 ruptured aneurysm 51 hepatocellular carcinoma 51 NOLVADEX 51 Bivalirudin 51 restenosis 51 Idiopathic pulmonary fibrosis 51 arterial calcification 51 vaginal atrophy 51 hemorrhagic bleeding 51 peginterferon 51 coronary artery bypass grafts 51 diabetic retinopathy DR 51 Thal Dex 51 symptomatic atrial fibrillation 51 impaired fasting glucose 51 Restless Legs Syndrome RLS 51 cabazitaxel 51 magnesium intake 51 cardiovascular diseases 51 insulin detemir 51 clonic seizures 51 valproate 51 precancerous cervical 51 laboratory abnormalities 51 chlorambucil 51 ACE Inhibitors 51 metformin Glucophage 51 MADIT CRT trial 51 serum calcium levels 51 bone fracture 51 HoFH 51 resynchronization therapy 51 hour bronchodilation 51 chronic rhinosinusitis 51 antiplatelet medications 51 urate levels 51 preterm delivery 51 biochemical recurrence 51 composite endpoint 51 hepatocellular cancer 51 genital herpes infections 51 pacemakers implanted 51 Abdominal aortic aneurysms 51 exemestane 51 failure ADHF 51 Hodgkin lymphoma HL 51 ventricular fibrillation VF 51 sirolimus stent 51 QT prolongation 51 Cardiovascular disease 51 warfarin 51 cervical lesions 51 Mucositis 51 diabetic nephropathy 51 ductal cancer 51 platelet reactivity 51 CDI recurrence 51 platelet inhibition 51 Colorectal cancers 51 postoperative morbidity 51 amniotic fluid embolism 51 hyperuricemia 51 abnormal mammogram 51 segment elevation myocardial 51 relapsing remitting MS RRMS 51 abacavir 51 cervical spine fractures 51 postsurgical complications 51 ziprasidone Geodon 51 systemic scleroderma 51 aldosterone antagonists 51 rhythm abnormalities 51 Heavy menstrual bleeding 51 polycystic ovary syndrome PCOS 51 depressive symptoms 51 aneurysm rupture 51 STRIDE PD 51 ischemic vascular 51 lipid lowering medication 51 NSTE ACS 51 Rasilez Tekturna 51 SHPT 51 ADEs 51 Hb A1C 51 haloperidol Haldol 51 urgent coronary revascularization 51 gastrointestinal bleeds 51 osteoporotic vertebral compression fractures 51 statins 51 relapsed AML 51 IBS symptoms 51 BRCA2 gene mutation 51 symptomatic aortic stenosis 51 abnormal Pap 51 virologic response 51 salmeterol fluticasone propionate 51 geographic atrophy 51 ancrod 51 moderate renal impairment 51 obstetric complications 51 Aortic aneurysms 51 idraparinux 51 drank decaffeinated coffee 51 dabigatran 51 Major Depressive Disorder MDD 51 Pulmonary embolism 51 fatal arrhythmias 51 Kepivance 51 Lp PLA2 51 leukemia AML 51 osteosarcomas 51 Taxus Stent 51 urinary incontinence 51 LYSTEDA 51 interferon therapy 51 Barrett Esophagus 51 valsartan amlodipine 51 undergoing CABG 51 bacteriuria 51 T2 lesions 51 uncoated stents 51 salmeterol HFA MDI 51 transaminase elevations 51 neurological complications 51 lupus erythematosus 51 Multaq R 51 oxycodone IR 51 pathologic fractures 51 ivabradine 51 overactive bladder OAB 51 TAXUS p value 51 HAM D# scores 51 Postmenopausal Women 51 revascularisation 51 HIV HCV coinfected 51 irbesartan 51 Wisconsin Sleep Cohort 51 plus MTX 51 angiotensin converting enzyme inhibitors 51 obstructive sleep apnea 51 tamoxifen therapy 51 placebo dexamethasone 51 rheumatic disease 51 Ramipril 51 PEGINTRON TM 51 disease CHD 51 biochemical relapse 51 briakinumab 51 Retinal vein occlusion 51 GnRH agonists 51 Raloxifene 51 neutrophil counts 51 acarbose 51 orthostatic hypotension 51 breastfed exclusively 51 CC genotype 51 alcoholic cirrhosis 51 OSAHS 51 lumiracoxib 51 autoimmune thyroid 51 Ulcerative Colitis 51 PREZISTA r arm 51 conjugated equine estrogen 51 depressive disorders 51 HPA axis suppression 51 unexplained syncope 51 deep vein thromboses 51 clot busting therapy 51 liver transplant recipients 51 branch RVO 51 rFVIIa 51 fluid overload 51 reflux disease 51 Stomach cancer 51 renal scarring 51 postmenopausal 51 aged ≥ 51 unresectable stage 51 von Willebrand disease 51 impaired renal 51 artery calcification